SUPPLEMENT IP · NDA · TECHNOLOGY TRANSFER

Formula Ownership, Confidentiality, and Transfer Risk. Defined.

This decision-support asset distinguishes background IP, contracted deliverables, confidentiality obligations, and technology transfer scope for enterprise supplement mandates. It is informational only and does not constitute legal advice.

MANDATORY ENTRY CONDITION

NDA BEFORE DISCLOSURE

TRANSFER DILIGENCE

PAID DISCOVERY MANDATORY

IP OWNERSHIP FRAMEWORK

Not All IP Is Created Equal. Understand What You Own Before Production Starts.

Supplement formula IP risk emerges when ownership categories are undefined. This framework distinguishes background IP, contracted deliverables, confidentiality scope, and technology transfer package — the four categories that determine who owns what at every stage of the manufacturing relationship.

IP Ownership Framework: categories, definitions, ownership, and contract scope
IP CATEGORYDEFINITIONOWNERSHIPCONTRACT SCOPE
BACKGROUND IPIP existing prior to engagement: your formulas, trade secrets, brand dataORIGINATOR RETAINS FULL RIGHTSCDMO GRANTED ACCESS FOR MANUFACTURING ONLY
CONTRACTED DELIVERABLESFormulation work, dossiers, and MBR documents created under SoWASSIGNED TO CLIENT UPON FULL PAYMENTDEFINED IN SIGNED STATEMENT OF WORK
CONFIDENTIALITY PERIMETERAll data exchanged during scoping, R&D, and production phasesGoverned by mutual NDA signed before technical disclosureISO 27001:2023 INFORMATION SECURITY CONTROLS ACTIVE
TECH TRANSFER PACKAGEMBR, SOP set, analytical release methods, and qualification dataTRANSFERRED TO CLIENT AS CONTRACTUAL DELIVERABLETRANSFER SCOPE DEFINED IN PAID DISCOVERY OUTPUT

SCROLL HORIZONTALLY TO REVIEW FULL FRAMEWORK

TRANSFER PROCESS ARCHITECTURE

Five-Stage Technology Transfer. No Undisclosed Complexity.

Each stage gates the next. No manufacturing commitment is made before legal controls, diligence, and contractual scope are established. This sequence protects your programme timeline and your IP perimeter.

01

MUTUAL NDA EXECUTION

Signed mutual NDA establishes the confidentiality perimeter before any technical data is exchanged. No formula intelligence is disclosed without this legal control in place.

02

PAID DISCOVERY DILIGENCE

Paid Discovery phase produces a transfer-risk map, MBR readiness assessment, and regulatory pressure-point analysis. The output is an operational decision framework for the transfer programme, not a sales call.

03

STATEMENT OF WORK & IP SCHEDULE

A signed SoW defines contracted deliverables, IP assignment terms, payment milestones, and transfer package scope. Contracted deliverables become client property upon payment completion.

04

MBR REVIEW & PROCESS TRANSFER

Master Batch Record is reviewed, gaps identified, and process parameters transferred to our qualified manufacturing line under ISO 22000 GMP controls. All analytical release methods are validated.

05

DOSSIER & TRANSFER PACKAGE HANDOFF

Full transfer package — MBR, SOP set, analytical methods, PPQ data — is delivered to the client. The dossier becomes a transaction-grade balance-sheet asset. Regulatory interpretation remains the client's legal counsel's remit.

TRANSFER RISK REALITY

Tech Transfer Fails When Diligence Is Skipped.

The most common technology transfer failures arise from undisclosed MBR gaps, unvalidated analytical methods, and missing stability data — not from manufacturing capability. Paid Discovery surfaces these gaps before they become production failures. We do not accept technology transfers without diligence.

THIS ASSET IS INFORMATIONAL ONLY. NOT LEGAL ADVICE. CONSULT QUALIFIED LEGAL COUNSEL FOR IP STRATEGY.

VERIFIED GOVERNANCE CONTROLS

INFORMATION SECURITY

ISO 27001:2023

AUDITED BY POLCARGO GROUP — FORMULA DATA ACCESS IS ROLE-GATED AND LOGGED

MANUFACTURING QUALITY

ISO 22000

GMP CONTROLS — ANALYTICAL RELEASE ON EVERY BATCH

OPERATING RECORD

17 YEARS

ZERO CLIENT QA COMPLAINTS

ENTRY QUALIFICATION

IP, NDA, and Transfer Risk Resolved Before Commitment.

Our Paid Discovery process requires a structured diligence investment before any manufacturing commitment. This protects your IP perimeter, surfaces transfer-risk points, and delivers a go / no-go board package with defined next steps. This page does not constitute legal advice. Consult qualified legal counsel for your specific IP and regulatory strategy.

Frequently Asked Questions

Who owns the supplement formula IP after production?
Background IP (formulas, trade secrets existing before engagement) remains with the originating client at all times. Contracted deliverables created under the signed Statement of Work are assigned to the client upon full payment. Ownership terms are contractually defined before any technical work begins — not assumed.
What does the NDA cover and when is it signed?
The mutual NDA covers all technical, commercial, and formulation data exchanged during scoping, R&D, and production phases. It is signed before any technical disclosure — specifically before formula data, ingredient ratios, or manufacturing parameters are shared. This is not a formality; it is a structural legal control enforced under our ISO 27001:2023 information security framework.
What is included in the Technology Transfer Package?
The Technology Transfer Package includes the Master Batch Record (MBR), Standard Operating Procedure (SOP) set, analytical release methods, and process qualification (PPQ) data. The exact scope is defined in the Paid Discovery output and formalised in the signed Statement of Work. This package becomes a contractual deliverable owned by the client.
Does Olympia Biosciences™ guarantee regulatory approval through the tech transfer?
No. Regulatory approval decisions are made by competent authorities, not by CDMOs. We deliver transfer-ready manufacturing documentation that meets EU regulatory standards (GMP, EU Food Supplements Directive, EFSA guidelines), but regulatory outcomes depend on the client's product category, claims strategy, and target markets. Clients are advised to retain qualified regulatory counsel for approval strategy.
Why is Paid Discovery mandatory before a technology transfer?
Technology transfer without diligence is a liability, not a service. Paid Discovery verifies MBR completeness, identifies transfer-risk points, confirms regulatory compliance status, and establishes realistic timelines before committing manufacturing resources. It protects both the client's programme and our production schedule from undisclosed complexity.